KAREN LANE: Open Payments
NPI 1063544666 · GREENEVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$673 in 35 payments from 9 companies in 2025. Trend: 2023 $809 · 2024 $589 · 2025 $673
Food & beverage: $673
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 9 | $161 |
| Otsuka America Pharmaceutical, Inc. | 5 | $99 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $99 |
| Vanda Pharmaceuticals Inc. | 4 | $88 |
| Lundbeck LLC | 4 | $65 |
| ABBVIE INC. | 3 | $52 |
| Neurocrine BioSciences, Inc. | 2 | $43 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| Axsome Therapeutics, Inc. | 2 | $29 |
Products named: AUSTEDO XR, CAPLYTA, REXULTI, ABILIFY MAINTENA, HETLIOZ, VRAYLAR, INGREZZA, COBENFY.
Industry payments across TN — which companies pay providers there.
